Private company

Societal CDMO, Inc.

American pharmaceutical preparations company based in Exton, active since 2007. Summary from the record

Last updated Oct 19, 2026.

Overview

IndustryPharmaceutical Preparations²
HeadquartersExton, United States²
Incorporated inPA³
Business address1 E. Uwchlan Ave, Suite 112, Exton, Pa 19341³
Filer categoryNon-accelerated filer, Smaller reporting company³
Legal formBusiness Corporation²
LEI2549004EL1Z016VYWA54²
StatusActive²
LEI statusLapsed (not renewed)²
Registered address1 E. UWCHLAN AVE, 19341 Exton, United States²
Registered withPennsylvania Department of State, 3769102²

See how the biggest companies compare on our leaderboards

On February 28, 2024, we entered into an Agreement and Plan of Merger, or the Merger Agreement, with CoreRx, Inc., or CoreRx, and Cane Merger Sub, Inc., a wholly owned subsidiary of CoreRx, or Merger Sub. Pursuant to the Merger Agreement, and upon the terms and subject to the conditions therein, CoreRx will commence a tender offer, or the Offer, to acquire all of our issued and outstanding shares of common stock, par value $0.01 per share, for approximately $1.10 per share of our common stock, or the Offer Price, in cash, subject to any applicable withholding of taxes and without interest. The Offer will initially expire one minute following 11:59 p.m. (Eastern Time) on the date that is 20 business days following the commencement of the Offer, subject to extension under certain circumstances.⁴ From its latest annual report

Financials

From the company’s reports to the SEC. Every number links to the filing it came from.

Key numbers, fiscal 2023

-3.8%Operating margin⁵

-14.0%Net margin⁵

4.9%Revenue growth, 2023⁵

-22.6%Return on equity⁵

0.01×Debt to equity⁵

-$9.2MFree cash flow⁵

Where the money goes

Where each dollar of revenue went, fiscal 2023

Cost of revenueSelling, general and admin

Cost of revenue71¢$76.5M
Selling, general and admin20¢$21.0M
Interest9¢$10.0M
Income tax0¢$132.0K

Out of $94.6M in revenue.⁵ The company lost money this year.

Financial statements

Revenue⁶⁷⁸⁹⁵$94.6M in 2023+32% since 2017

Operating income¹⁰⁷⁸⁹⁵-$3.6M in 2023−91% since 2017

Net income⁶⁷⁸⁹⁵-$13.3M in 2023−73% since 2017

Fiscal year	2017	2018	2019	2020	2021	2022	2023
Revenue	$71.8M⁶	$77.3M⁷	$99.2M⁸	$66.5M⁹	$75.4M⁵	$90.2M⁵	$94.6M⁵
Cost of revenue	$38.2M⁶	$43.2M⁷	$51.0M⁸	$54.1M⁹	$55.5M⁵	$67.1M⁵	$76.5M⁵
Research and development	$4.5M⁶	$4.4M⁷
Selling, general and admin	$14.3M⁶	$14.4M⁷	$19.9M⁸	$18.1M⁹	$18.4M⁵	$22.0M⁵	$21.0M⁵
Operating expenses					$74.9M⁵	$89.9M⁵	$98.2M⁵
Operating income	-$40.3M¹⁰	$12.5M⁷	$23.6M⁸	-$8.3M⁹	$412.0K⁵	$279.0K⁵	-$3.6M⁵
Interest	$12.0M⁶	$8.1M⁷	$19.0M⁸	$19.2M⁹	$15.1M⁵	$14.2M⁵	$10.0M⁵
Income before tax					-$11.4M⁵	-$18.8M⁵	-$13.1M⁵
Income tax	$7.3M⁶	$17.4M⁷	$0⁸	$0⁹	$0⁵	$1.1M⁵	$132.0K⁵
Net income	-$50.1M⁶	-$79.7M⁷	-$18.6M⁸	-$27.5M⁹	-$11.4M⁵	-$19.9M⁵	-$13.3M⁵
Earnings per share	-$2.63⁶	-$3.90⁷	-$0.83⁸	-$1.16⁹	-$0.26⁵	-$0.34⁵	-$0.14⁵
Earnings per share (diluted)	-$2.63⁶	-$3.90⁷	-$0.79⁸	-$1.16⁹	-$0.26⁵	-$0.34⁵	-$0.14⁵
Shares (weighted, basic)					44.1M shares⁵	57.9M shares⁵	95.2M shares⁵
Shares (weighted, diluted)					44.1M shares⁵	57.9M shares⁵	95.2M shares⁵

Total assets¹⁰⁶⁷⁸⁹⁵$153.5M in 2023−18% since 2017

Total liabilities¹⁰⁶⁷⁸⁹⁵$94.8M in 2023−40% since 2017

Shareholders’ equity⁷⁸⁹⁵$58.7M in 2023+103% since 2017

Cash¹⁰⁶⁷⁸⁹⁵$8.1M in 2023−87% since 2017

Long-term debt¹⁰⁶⁷⁸⁹⁵$339.0K in 2023−99% since 2017

Fiscal year	2017	2018	2019	2020	2021	2022	2023
Cash	$61.0M¹⁰	$38.5M⁶	$19.1M⁷	$23.8M⁸	$25.2M⁹	$15.0M⁵	$8.1M⁵
Receivables					$11.9M⁹	$15.9M⁵	$16.6M⁵
Inventory					$8.9M⁹	$10.3M⁵	$10.3M⁵
Current assets	$87.3M¹⁰	$71.1M⁶	$60.2M⁷	$54.1M⁸	$57.5M⁹	$55.6M⁵	$53.5M⁵
Property, plant and equipment					$51.7M⁹	$50.4M⁵	$49.8M⁵
Goodwill					$41.1M⁹	$41.1M⁵	$41.1M⁵
Intangible assets					$3.8M⁹	$2.9M⁵	$2.2M⁵
Total assets	$186.2M¹⁰	$155.5M⁶	$110.5M⁷	$103.4M⁸	$160.3M⁹	$157.4M⁵	$153.5M⁵
Accounts payable					$2.1M⁹	$1.5M⁵	$1.3M⁵
Short-term debt					$2.0M⁹	$7.6M⁵	$36.8M⁵
Current liabilities	$49.9M¹⁰	$29.0M⁶	$6.5M⁷	$7.8M⁸	$17.7M⁹	$22.8M⁵	$50.0M⁵
Long-term debt	$53.6M¹⁰	$64.2M⁶	$110.3M⁷	$108.1M⁸	$95.5M⁹	$31.0M⁵	$339.0K⁵
Total liabilities	$157.4M¹⁰	$175.0M⁶	$117.2M⁷	$117.5M⁸	$118.3M⁹	$97.6M⁵	$94.8M⁵
Retained earnings					-$245.8M⁹	-$265.6M⁵	-$278.9M⁵
Shareholders’ equity	$28.8M⁷	-$19.5M⁸	-$6.7M⁹	-$14.1M⁵	$42.1M⁵	$59.9M⁵	$58.7M⁵
Shares outstanding	19.1M shares¹⁰	21.8M shares⁶	23.3M shares⁷	28.6M shares⁸	46.7M shares⁹	84.6M shares⁵	104.9M shares⁵

Cash from operations¹⁰⁵-$1.0M in 2023−94% since 2017

Capital spending⁶⁷⁸⁹⁵$8.2M in 2023+52% since 2017

Free cash flow¹⁰⁵-$9.2M in 2023−59% since 2017

Fiscal year	2017	2018	2019	2020	2021	2022	2023
Cash from operations	-$17.0M¹⁰	-$43.1M¹⁰			$10.9M⁵	-$3.6M⁵	-$1.0M⁵
Stock-based compensation					$6.5M⁵	$5.4M⁵	$5.0M⁵
Capital spending	$5.4M⁶	$7.2M⁷	$8.3M⁸	$7.6M⁹	$5.3M⁵	$8.4M⁵	$8.2M⁵
Free cash flow	-$22.4M	-$50.3M			$5.6M	-$12.0M	-$9.2M
Cash from investing					-$29.3M⁵	-$8.4M⁵	-$8.2M⁵
Cash from financing					$19.9M⁵	$1.8M⁵	$2.3M⁵

Compare Societal CDMO, Inc. with another company

Leadership

Who has led Societal CDMO, Inc., and when. Pick a name to see everywhere that person has worked.

Chief executive

President

Geraldine Henwood2014–2020

Chief financial officer

Chief operating officer

Michael Celano2018–2019

201520202025

Chief executive officerJ. David Enloe Jr. Dec 18, 2020 to Apr 8, 2024¹³
Chief executive officerGeraldine Henwood Mar 13, 2014 to Dec 9, 2020¹⁴
PresidentGeraldine Henwood Mar 13, 2014 to Dec 9, 2020¹⁴
Chief financial officerRyan David Lake Jan 4, 2018 to Apr 8, 2024¹⁵
Chief financial officerMichael Celano Jul 5, 2016 to Oct 2, 2017¹⁶
Chief operating officerMichael Celano Jan 4, 2018 to Feb 19, 2019¹⁷

Board members and other officers (22)

Senior VP, Finance & CAORyan David Lake Jun 7, 2017 to Jun 7, 2017¹⁸
Executive VP, Business Dev.Jyrki Mattila Aug 21, 2017 to Jan 4, 2018¹⁹
Chief Commercial OfficerFred Graff Feb 18, 2016 to Jan 22, 2018²⁰
Chief Medical OfficerStewart McCallum Dec 2, 2015 to Jan 22, 2018²¹
Senior VP-Reg./QualityDiane Myers Mar 13, 2014 to Jan 22, 2018²²
CAO/ControllerDonna Nichols Mar 13, 2014 to Jan 20, 2017²³
Senior VP, DevelopmentRandall Mack Mar 13, 2014 to Jan 22, 2018²⁴
Board memberMathew Paul Arens Aug 25, 2023 to Apr 8, 2024²⁵
Board memberElena Cant Sep 6, 2022 to Apr 8, 2024²⁶
Board memberLaura L. Parks Jun 21, 2021 to Apr 8, 2024²⁷
Board memberJ. David Enloe Jr. Dec 18, 2020 to Apr 8, 2024¹³
Board memberArnaud Ajdler Mar 27, 2019 to May 11, 2020²⁸
Board memberBryan M. Reasons Mar 6, 2017 to Apr 8, 2024²⁹
Board memberDiane Myers Dec 5, 2016 to Oct 2, 2017³⁰
Board memberKaren Flynn Sep 8, 2015 to Dec 16, 2019³¹
Board memberAbraham Ludomirski Mar 13, 2014 to Nov 3, 2016³²
Board memberAlfred Altomari Mar 13, 2014 to Dec 9, 2019³³
Board memberGeraldine Henwood Mar 13, 2014 to May 17, 2021¹⁴
Board memberMichael Berelowitz Mar 13, 2014 to May 20, 2022³⁴
Board memberWayne Weisman Mar 13, 2014 to Apr 8, 2024³⁵
Board memberWilliam Ashton Mar 13, 2014 to Apr 8, 2024³⁶
Board memberWinston J. Churchill Mar 13, 2014 to Apr 8, 2024³⁷

Former names

Recro Pharma, Inc.Oct 24, 2013 to Mar 21, 2022³

Timeline

Dec 18, 2020New chief executive J. David Enloe Jr. becomes CEO¹³
Mar 13, 2014New chief executive Geraldine Henwood becomes CEO¹⁴
Nov 15, 2007Founded Societal CDMO, Inc. is founded²

Filings

240 filings to the SEC since October 2021: 4 annual reports, 7 quarterly reports, 36 major events, 104 insider forms, 21 large holders, 68 other. The latest 20:

The 240 filings since October 2021 can be filtered by form type and year here when JavaScript is on.

Every filing from the last five years, summarized. The full record is on SEC EDGAR.

Insider trades

35 open-market trades by officers, directors and large owners since October 2021: 29 buys and 6 sales. Grants, option exercises and gifts are left out.

Date	Who	Trade	Shares	Price	Value	Filing
Aug 28, 2023	Ashton WilliamDirector	Buy	22,222	$0.46	$10.2K	Form 4
Aug 28, 2023	ENLOE J DAVID JRChief Executive Officer	Buy	125,000	$0.40	$50.0K	Form 4
Aug 28, 2023	Reasons Bryan M.Director	Buy	62,500	$0.40	$25.0K	Form 4
Aug 28, 2023	Weisman WayneDirector	Buy	62,500	$0.40	$25.0K	Form 4
Aug 28, 2023	Miller James CharlesDirector	Buy	37,500	$0.40	$15.0K	Form 4
Aug 28, 2023	Cant ElenaDirector	Buy	30,000	$0.40	$12.0K	Form 4
Aug 28, 2023	CHURCHILL WINSTON JDirector	Buy	62,500	$0.40	$25.0K	Form 4
Aug 24, 2023	AWM Investment Company, Inc.10% owner	Buy	140,000	$0.40	$56.0K	Form 4
Aug 24, 2023	First Light Asset Management, LLCDirector	Buy	6,250,000	$0.40	$2.5M	Form 4
Apr 27, 2023	AWM Investment Company, Inc.10% owner	Sale	370,000	$0.70	$259.0K	Form 4
Nov 15, 2022	ENLOE J DAVID JRChief Executive Officer	Buy	660	$1.71	$1.1K	Form 4
Oct 17, 2022	ENLOE J DAVID JRChief Executive Officer	Buy	625	$1.69	$1.1K	Form 4
Sep 15, 2022	ENLOE J DAVID JRChief Executive Officer	Buy	714	$1.41	$1.0K	Form 4
Aug 15, 2022	ENLOE J DAVID JRChief Executive Officer	Buy	757	$1.26	$954	Form 4
Jul 15, 2022	ENLOE J DAVID JRChief Executive Officer	Buy	1,150	$0.81	$932	Form 4
Jun 15, 2022	ENLOE J DAVID JRChief Executive Officer	Buy	1,562	$0.68	$1.1K	Form 4
May 16, 2022	ENLOE J DAVID JRChief Executive Officer	Buy	1,086	$0.96	$1.0K	Form 4
Apr 20, 2022	AWM Investment Company, Inc.10% owner	Buy	12,100	$1.56	$18.9K	Form 4
Apr 19, 2022	AWM Investment Company, Inc.10% owner	Buy	12,100	$1.56	$18.9K	Form 4
Apr 18, 2022	AWM Investment Company, Inc.10% owner	Buy	15,600	$1.55	$24.2K	Form 4

All 35 trades can be filtered by person here when JavaScript is on.

From Forms 4 filed with the SEC.

Major holders

Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.

First Light Asset Management, LLCSC 13D/A, 4 filings Jan 5, 2023 to Apr 9, 2024³⁸
Beryl Capital Management LLCSC 13G, 1 filing Apr 1, 2024³⁹
CORERX INCSC 13D, 1 filing Mar 6, 2024⁴⁰
AWM Investment Company, Inc.SC 13G/A, 3 filings Feb 11, 2022 to Feb 14, 2024⁴¹
Laurence W. LyttonSC 13G/A, 2 filings Aug 31, 2023 to Feb 14, 2024⁴²
Cowen Prime Advisors LLCSC 13G, 1 filing Aug 7, 2023⁴³
Athyrium Funds GP Holdings LLCSC 13G/A, 1 filing Feb 14, 2023⁴⁴
Samjo Capital LLCSC 13G/A, 2 filings Feb 8, 2022 to Feb 10, 2023⁴⁵
Railroad Ranch Capital Management, LPSC 13D/A, 3 filings Jun 27, 2022 to Dec 16, 2022⁴⁶
Gerald Joseph Yakatan & Una Yakatan Family Trust dated April 4, 1989 as amended & fully restated on May 3, 2017SC 13G, 1 filing Mar 24, 2022⁴⁷
Portolan Capital Management, LLCSC 13G/A, 1 filing Feb 11, 2022⁴⁸
RENAISSANCE TECHNOLOGIES LLCSC 13G/A, 1 filing Feb 11, 2022⁴⁹

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARSocietal CDMO, Inc. filings on SEC EDGAR
2
GLEIFSocietal CDMO, Inc. LEI record (2549004EL1Z016VYWA54)
3
SEC EDGARSocietal CDMO, Inc. filings on SEC EDGAR
4
SEC EDGARSocietal CDMO, Inc. annual report, Item 1 (Business)
5
SEC EDGARSocietal CDMO, Inc. 10-K for fiscal 2023
6
SEC EDGARSocietal CDMO, Inc. 10-K for fiscal 2017
7
SEC EDGARSocietal CDMO, Inc. 10-K for fiscal 2018
8
SEC EDGARSocietal CDMO, Inc. 10-K for fiscal 2019
9
SEC EDGARSocietal CDMO, Inc. 10-K for fiscal 2020
10
SEC EDGARSocietal CDMO, Inc. 10-K for fiscal 2017
11
SEC EDGARSocietal CDMO, Inc. 10-Q for fiscal 2023
12
SEC EDGARSocietal CDMO, Inc. 10-Q for fiscal 2023
13
SEC EDGARJ. David Enloe Jr., Chief executive officer
14
SEC EDGARGeraldine Henwood, Chief executive officer
15
SEC EDGARRyan David Lake, Chief financial officer
16
SEC EDGARMichael Celano, Chief financial officer
17
SEC EDGARMichael Celano, Chief operating officer
18
SEC EDGARRyan David Lake, Senior VP, Finance & CAO
19
SEC EDGARJyrki Mattila, Executive VP, Business Dev.
20
SEC EDGARFred Graff, Chief Commercial Officer
21
SEC EDGARStewart McCallum, Chief Medical Officer
22
SEC EDGARDiane Myers, Senior VP-Reg./Quality
23
SEC EDGARDonna Nichols, CAO/Controller
24
SEC EDGARRandall Mack, Senior VP, Development
25
SEC EDGARMathew Paul Arens, Board member
26
SEC EDGARElena Cant, Board member
27
SEC EDGARLaura L. Parks, Board member
28
SEC EDGARArnaud Ajdler, Board member
29
SEC EDGARBryan M. Reasons, Board member
30
SEC EDGARDiane Myers, Board member
31
SEC EDGARKaren Flynn, Board member
32
SEC EDGARAbraham Ludomirski, Board member
33
SEC EDGARAlfred Altomari, Board member
34
SEC EDGARMichael Berelowitz, Board member
35
SEC EDGARWayne Weisman, Board member
36
SEC EDGARWilliam Ashton, Board member
37
SEC EDGARWinston J. Churchill, Board member
38
SEC EDGARFirst Light Asset Management, LLC SC 13D/A on Societal CDMO, Inc.
39
SEC EDGARBeryl Capital Management LLC SC 13G on Societal CDMO, Inc.
40
SEC EDGARCORERX INC SC 13D on Societal CDMO, Inc.
41
SEC EDGARAWM Investment Company, Inc. SC 13G/A on Societal CDMO, Inc.
42
SEC EDGARLaurence W. Lytton SC 13G/A on Societal CDMO, Inc.
43
SEC EDGARCowen Prime Advisors LLC SC 13G on Societal CDMO, Inc.
44
SEC EDGARAthyrium Funds GP Holdings LLC SC 13G/A on Societal CDMO, Inc.
45
SEC EDGARSamjo Capital LLC SC 13G/A on Societal CDMO, Inc.
46
SEC EDGARRailroad Ranch Capital Management, LP SC 13D/A on Societal CDMO, Inc.
47
SEC EDGARGerald Joseph Yakatan & Una Yakatan Family Trust dated April 4, 1989 as amended & fully restated on May 3, 2017 SC 13G on Societal CDMO, Inc.
48
SEC EDGARPortolan Capital Management, LLC SC 13G/A on Societal CDMO, Inc.
49
SEC EDGARRENAISSANCE TECHNOLOGIES LLC SC 13G/A on Societal CDMO, Inc.